New Therapies for Primary Pulmonary Hypertension

This publication has 39 references indexed in Scilit:

• The Effect of High Doses of Calcium-Channel Blockers on Survival in Primary Pulmonary Hypertension
  New England Journal of Medicine, 1992
• Survival in Patients with Primary Pulmonary Hypertension
  Annals of Internal Medicine, 1991
• Prediction of favourable responses to long term vasodilator treatment of pulmonary hypertension by short term administration of epoprostenol (prostacyclin) or nifedipine.
  Heart, 1988
• Primary Pulmonary Hypertension
  Annals of Internal Medicine, 1987
• The Place of Prostacyclin in the Clinical Management of Primary Pulmonary Hypertension
  American Review of Respiratory Disease, 1987
• High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.
  Circulation, 1987
• Primary pulmonary hypertension: natural history and the importance of thrombosis.
  Circulation, 1984
• Vasodilators and Prostaglandin Inhibitors in Primary Pulmonary Hypertension
  Annals of Internal Medicine, 1982
• Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment.
  Heart, 1982
• PROSTACYCLIN AND PROSTAGLANDIN E1 FOR SEVERE IDIOPATHIC PULMONARY ARTERY HYPERTENSION
  The Lancet, 1980